IMMUNOR AS
home - Immunor AS
Immunor AS is a Norwegian-based vaccine developer unlike any other. Building on comprehensively patented IP of unique elegance and power, Immunor AS is in
Links
Organization
- CEO
- AS
- Chairman of the board
- BS
Birger Sørensen1955
- Years since formation
- 11 years
- since Nov 13, 2014
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 553,705,360
- 1 share class
- Total number of shareholders
- 35
- 24 companies, 11 persons
Financials
- Annual total result 2024
- -1,394,736
- NOK
- Total equity 2024
- -105,943
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AS | Managing Director/CEO | 22.03 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
BS 1955 | Chairman | 30.81 % indirectly |
AA 1959 | Board Member | 2.97 % indirectly |
DA | Board Member | 3.29 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
BS 1955 | Chairman | 30.81 % indirectly |
AS | Managing Director/CEO | 22.03 % indirectly |
HS | - | 11.02 % indirectly |
DA | Board Member | 3.29 % indirectly |
AA 1959 | Board Member | 2.97 % indirectly |
JM | - | 1.35 % indirectly |
RS | - | 1.35 % indirectly |
Last update: May 13, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 183,009,643 | 33.05 % | |
| Ordinary shares | 170,575,483 | 30.81 % | |
| Ordinary shares | 72,707,891 | 13.13 % | |
| Ordinary shares | 18,227,631 | 3.29 % | |
| Ordinary shares | 16,427,629 | 2.97 % | |
| Ordinary shares | 11,562,113 | 2.09 % | |
| Ordinary shares | 10,500,000 | 1.9 % | |
| Ordinary shares | 7,462,687 | 1.35 % | |
| Ordinary shares | 7,462,687 | 1.35 % | |
| Ordinary shares | 6,818,028 | 1.23 % | |
| Ordinary shares | 6,043,310 | 1.09 % | |
| Ordinary shares | 5,000,000 | 0.9 % | |
KS 1978 | Ordinary shares | 5,000,000 | 0.9 % |
| Ordinary shares | 4,524,524 | 0.82 % | |
| Ordinary shares | 4,000,000 | 0.72 % | |
| Ordinary shares | 3,136,360 | 0.57 % | |
| Ordinary shares | 2,551,520 | 0.46 % | |
| Ordinary shares | 2,523,303 | 0.46 % | |
| Ordinary shares | 2,045,410 | 0.37 % | |
GU 1963 | Ordinary shares | 1,841,791 | 0.33 % |
| Ordinary shares | 1,729,316 | 0.31 % | |
| Ordinary shares | 1,551,804 | 0.28 % | |
| Ordinary shares | 1,551,804 | 0.28 % | |
| Ordinary shares | 1,503,134 | 0.27 % | |
| Ordinary shares | 1,200,000 | 0.22 % | |
DA | Ordinary shares | 1,052,936 | 0.19 % |
| Ordinary shares | 853,561 | 0.15 % | |
| Ordinary shares | 805,687 | 0.15 % | |
CB | Ordinary shares | 608,776 | 0.11 % |
OL 1963 | Ordinary shares | 340,900 | 0.06 % |
TI | Ordinary shares | 340,138 | 0.06 % |
ØM | Ordinary shares | 204,540 | 0.04 % |
PS 1952 | Ordinary shares | 200,000 | 0.04 % |
| Ordinary shares | 200,000 | 0.04 % | |
| Ordinary shares | 142,754 | 0.03 % |
Shares owned by the IMMUNOR AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010813736 | 16,350,000 | 35.87 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2021 |
|---|---|---|---|
Total operating income | 0 | 0 | 305,043 |
Annual Total Result | -1,394,736 | -417,741 | -223,336 |
Total assets | 403,696 | 53,205 | 176,599 |
Total liabilities | 509,639 | 3,180,581 | 2,000,772 |
Total equity | -105,943 | -3,127,376 | -1,824,173 |
P&L
| Year | 2024 | 2023 | 2021 |
|---|---|---|---|
Total operating income | 0 | 0 | 305,043 |
Total operating costs | 1,328,316 | 172,295 | 567,114 |
Operating result | -1,328,316 | -172,295 | -262,071 |
Financial income/costs | -66,421 | -245,446 | 38,735 |
Profit before tax | -1,394,736 | -417,741 | -223,336 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -1,394,736 | -417,741 | -223,336 |
Balance overview
| Year | 2024 | 2023 | 2021 |
|---|---|---|---|
Total fixed assets | 36,216 | 36,216 | 126,600 |
Total current assets | 367,480 | 16,989 | 49,999 |
Total assets | 403,696 | 53,205 | 176,599 |
Short term debt | 159,216 | 710,586 | 248,872 |
Long term debt | 350,423 | 2,469,995 | 1,751,900 |
Total liabilities | 509,639 | 3,180,581 | 2,000,772 |
Contributed capital | 4,466,719 | 50,550 | 24,334 |
Retained earnings | -4,572,662 | -3,177,927 | -1,848,507 |
Total equity | -105,943 | -3,127,376 | -1,824,173 |
Total equity and liabilities | 403,697 | 53,205 | 176,599 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises